Consent, GA, Mega, Footer

Electromechanical Reshaping (EMR)

Scientists are developing a laser-free vision correction method called Electromechanical Reshaping (EMR), which uses low-level electrical currents instead of lasers or surgical incisions to correct vision. Developed by researchers at Occidental College and the University of California, Irvine, this experimental technique temporarily softens the eye's cornea so it can be molded into a new shape. [1, 2]

How Electromechanical Reshaping (EMR) Works
Unlike traditional LASIK, which permanently cuts and vaporises corneal tissue, EMR alters the eye on a molecular level: [1, 2, 3]
  1. Application: A specialised platinum "contact lens" is placed over the eye to act as an electrode. [1]
  2. Loosening: A mild, safe electrical current passes through the cornea, causing a controlled pH change. This temporarily disrupts the ionic bonds holding the collagen structure together, making the tissue pliable. [1, 2, 3]
  3. Molding: The softened cornea molds to the curvature of the contact lens template within roughly one minute. [1, 2]
  4. Setting: Once the electrical current is stopped and normal pH is restored, the structural bonds lock the cornea into its new, vision-corrected shape. [1, 2]
Why Researchers are Excited
  • Preserves Eye Structure: Because no tissue is carved away, the cornea retains its natural physical strength. [1]
  • Fewer Side Effects: EMR aims to eliminate common LASIK complications like severe dry eye syndrome and permanent nerve damage. [1]
  • Potentially Reversible: Because tissue is only rearranged rather than removed, the process could theoretically be tweaked or entirely reversed if a patient’s vision shifts over time. [1, 2]
  • Significantly Cheaper: The procedure relies on simple electrical equipment and custom lenses rather than multi-million-pound, highly complex laser systems. [1, 2]
Current Limitations and Next Steps
While promising, this technology is not yet available to the public. Initial proof-of-concept tests were successfully completed on ex vivo rabbit eyes, showing that the targeted focusing power could be corrected while maintaining cellular health. However, the research team must still conduct extensive live animal testing followed by rigorous human clinical trials before EMR can be approved for standard practice. [1, 2, 3, 4, 5]